Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Accrued Liabilities

v3.24.3
Note 7 - Accrued Liabilities
9 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Accrued liabilities
7.
Accrued liabilities:

Accrued liabilities as of September 30, 2024 and December 31, 2023 consisted of the following:

 

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Accrued personnel related costs

 

$

876

 

 

$

1,989

 

Accrued research and development expenses

 

 

6,466

 

 

 

6,527

 

Other accrued expenses

 

 

170

 

 

 

313

 

Total

 

$

7,512

 

 

$

8,829